Keyphrases
5-aminosalicylic Acid (5-ASA)
25%
Adverse Effect Profile
33%
Aminoglycosides
25%
Antifungal Prophylaxis
33%
Bedaquiline
58%
Capreomycin
33%
Clofazimine
25%
D-cycloserine
58%
Dapsone
58%
Delamanid
50%
Diagnostic Considerations
33%
Drug Interactions
58%
Drug Use
33%
Ethambutol
58%
Extended-spectrum β-lactamase
33%
Extensively Drug-resistant Tuberculosis
33%
Gatifloxacin
33%
Ginsenoside
33%
High Dose
33%
Infection Diagnosis
33%
Infection Treatment
33%
Kanamycin
33%
Leprosy
100%
Levofloxacin
33%
Liposomal Amphotericin B
33%
Methicillin-resistant Staphylococcus Aureus
33%
Moxifloxacin
33%
Multidrug Resistance
33%
Multidrug-resistant Tuberculosis (MDR-TB)
33%
Mycobacterium Leprae
33%
Mycobacterium Tuberculosis (M. tb)
33%
Older Adults
33%
Panax Ginseng
33%
Panax Notoginseng
33%
Pharmacokinetic Drug Interactions
33%
Pharmacokinetic Study
27%
Positive Blood Culture
33%
Pyrazinamide
58%
Rifamycin
58%
Side Effect Profile
33%
Staphylococcus Aureus Bacteremia
33%
Terizidone
25%
Tolerability
33%
Treatment Considerations
33%
Treatment Regimen
41%
Tuberculosis
100%
Tuberculosis Drugs
33%
Tuberculosis Treatment
50%
Urinary Tract Infection
33%
XDR-tuberculosis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
16%
Adverse Event
50%
Aminoglycoside
33%
Aminosalicylic Acid
33%
Amphotericin B
33%
Antibiotics
17%
Antifungal Agent
33%
Bedaquiline
66%
Capreomycin
33%
Carbapenem Derivative
33%
Clofazimine
33%
Cycloserine
66%
CYP3A
8%
Dapsone
66%
Daptomycin
20%
Delamanid
50%
Drug Interaction
33%
Ethambutol
66%
Extended Spectrum Beta Lactamase
33%
Extensively Drug-Resistant Tuberculosis
33%
Gatifloxacin
33%
Ginseng
33%
Hematologic Malignancy
16%
Isoniazid
66%
Kanamycin
33%
Latent Tuberculosis
16%
Leprosy
33%
Levofloxacin
33%
Linezolid
33%
Macrolide
33%
Methicillin Resistant Staphylococcus Aureus Infection
33%
Moxifloxacin
33%
Multi-Drug-Resistant Tuberculosis
33%
Multidrug Resistance
33%
Mycobacterium Tuberculosis
33%
Pharmacokinetics
50%
Polypeptide
33%
Pyrazinamide
66%
Quinolone Derivative
33%
Rifamycin
66%
Side Effect
33%
Spondylitis
13%
Systemic Mycosis
16%
Terizidone
33%
Thioacetazone
33%
Tolerability
33%
Tuberculosis
33%
Urinary Tract Infection
33%
Vancomycin
20%
Warfarin
8%